New research has revealed almost a quarter of Australians are not confident in the development of an effective vaccine against COVID-19.
A lung cancer drug that could save or extend the lives of 1000 Australians will have its cost slashed in the new year going from $90,000 per year to as low as $6.60 per script.
Liberal MP Craig Kelly said a small handful of bureaucrats in Australia are “ignoring the evidence” and denying Australians access to a medicine which all around the world is “shown to be saving lives”.
The federal government has secured a promising vaccine being developed at Oxford University after brokering a deal with a UK-based drug company.
Coronavirus trial drug Remdesivir has been approved for use in Australia as Victoria registers 216 new cases overnight.
The Nobel-prize winning drug saving the lives of stage three melanoma patients has been added to the PBS, saving patients more than $100,000 a year.